Parkinson (Edaravone Syringe) 1.5mg/ml x 20ml

Edaravone 1.5mg/ml x 20ml syringe is a neuroprotective agent used to slow disease progression in amyotrophic lateral sclerosis (ALS). This antioxidant formulation helps reduce oxidative stress in nerve cells. A-VONE brand edaravone syringe supports symptom management for ALS patients.

Strength

1.5mg/ml x 20ml

Pack Size

20ML AMP

Manufacturer / TM Owner

Pace Biotech

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Edaravone syringe 1.5mg/ml x 20ml is used to treat amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease. It helps slow functional decline by reducing oxidative damage in motor neurons. Patients with ALS often seek edaravone for symptom support and disease modification. This injectable form provides targeted delivery for therapeutic benefit.

Side Effects

Edaravone may help reduce fatigue and slow physical decline in ALS patients over time. Some users report improved daily function and reduced muscle stiffness. Headache and injection site reactions are commonly reported effects. These effects vary by individual and should be monitored by a healthcare provider.

Precautions & Warnings

Edaravone syringe should be handled with care to avoid contamination or improper administration. Store at controlled room temperature and protect from light. Patients with known allergies to edaravone or sulfites should avoid use. Always follow healthcare provider instructions for safe handling and disposal.

Avoid Interactions

Edaravone may interact with other medications that affect liver enzymes or blood flow. Caution is advised when combining with drugs that alter oxidative stress pathways. Alcohol and certain supplements may influence edaravone effects. Consult a healthcare provider before mixing with other therapies.

References

Frequently Asked Questions

Edaravone is used to slow disease progression in amyotrophic lateral sclerosis (ALS). It helps reduce oxidative stress in nerve cells.

Edaravone is given as an intravenous infusion over 60 minutes. Dosage and frequency are determined by a healthcare provider.

Common side effects include headache, injection site reactions, and bruising. Some patients may experience fatigue or constipation.

Edaravone is available by prescription only. Consult a healthcare provider for proper evaluation and prescription.

Edaravone is used for long-term ALS management under medical supervision. Regular monitoring is recommended to assess benefits and risks.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.